Massimo Loda, MD
Chair, Department of Oncologic Pathology, Dana-Farber Cancer Institute
Principal Investigator, Dana-Farber Cancer Institute
Chief, Division of Translational and Molecular Oncologic Pathology, Department of Pathology, Brigham & Women's Hospital
Professor of Pathology, Harvard Medical School
Associate Member, Broad Institute
Senior Surgical Pathologist, Brigham & Women’s Hospital
Director, Molecular Pathology Core Laboratory
Visiting Professor, Division of Cancer Studies, King's College, London
Associate Editor, American Journal of Pathology
Member, Integration Panel, Prostate Cancer, Department of Defense
Dr. Loda received his M.D. summa cum laude at the University of Milan, Italy. He is a physician-scientist, Professor of Pathology at Harvard Medical School, Chair of the Department of Oncologic Pathology at Dana Farber Cancer Institute, Associate Member of the Broad Institute and senior surgical pathologist at the Brigham & Women’s Hospital in Boston. Dr. Loda conceived, built and directs a state of the art Molecular Pathology Core Laboratory at the Dana Faber Cancer Institute. Dr. Loda is one of the pioneer molecular pathologists in the world and has discovered, and explored the mechanism of function of several important cancer biomarkers.
His laboratory has been focused for several years on metabolic alterations in prostate tumorigenesis, with a specific interest in lipid metabolism and its regulation. Our approach is multidisciplinary, utilizing cell lines, orthotopic tumor xenograft, genetically engineered murine models and human tumors. They have also been at the forefront in the invention and application of novel molecular pathology techniques such as ex vivo organotypic cultures, multiplexed immunohistochemistry and in situ hybridization, advances in image analysis and applying molecular techniques such as metabolic profiling to formalin-fixed, paraffin-embedded tissue.
Assistant: Joan Coraccio p: (617) 632-4705 | e: email@example.com